UC Davis Comprehensive Cancer Center https://www.ucdmc.ucdavis.edu/publish/rss/{$key} UC Davis Comprehensive Cancer Center news UC Davis Comprehensive Cancer Center https://www.ucdmc.ucdavis.edu/global/images/wordmarks/cancer_center.gif https://www.ucdmc.ucdavis.edu/publish/rss/cancercenter UC Davis Comprehensive Cancer Center news Knoepfler awarded childhood cancer research grant https://www.ucdmc.ucdavis.edu/publish/news/cancer/10118/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10118 SACRAMENTO, Calif. (June 25, 2015) - UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer. Thu, 25 Jun 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10118 Dorsey Griffith 2015-06-25T00:00:00Z Leiserowitz receives WAGO award https://www.ucdmc.ucdavis.edu/publish/news/cancer/10089/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10089 SACRAMENTO, Calif. (June 15, 2015) - Gary Leiserowitz, chief of gynecologic oncology and interim chair of the Department of Obstetrics and Gynecology, received the Western Association of Gynecologic Oncologists (WAGO) James F. Nolan Award June 12 at the 2015 Annual Meeting in Santa Rosa. Mon, 15 Jun 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10089 Susan Mar 2015-06-15T00:00:00Z UC Davis Division of Pediatric Hematology-Oncology welcomes new chief https://www.ucdmc.ucdavis.edu/publish/news/cancer/10082/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10082 SACRAMENTO, Calif. (June 15, 2015) - Marcio H. Malogolowkin, an international leader in the treatment of rare pediatric liver tumors, has joined UC Davis as the new chief of the UC Davis Division of Pediatric Hematology and Oncology. Mon, 15 Jun 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10082 Inessa Samusenko 2015-06-15T00:00:00Z Revealing kidney cancer's secret https://www.ucdmc.ucdavis.edu/publish/news/cancer/10017/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10017 SACRAMENTO, Calif. (May 14, 2015) - An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results, published in the journal Cancer Research, point to new therapeutic options for this particularly deadly cancer. Thu, 14 May 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10017 Dorsey Griffith 2015-05-14T00:00:00Z Surgery for terminal cancer patients still common https://www.ucdmc.ucdavis.edu/publish/news/cancer/9965/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9965 SACRAMENTO, Calif. (May 1, 2015) - The number of surgeries performed on terminally ill cancer patients has not dropped in recent years ­, despite more attention to the importance of less invasive care for these patients to relieve symptoms and improve quality of life. But new research from UC Davis also finds that the morbidity and mortality among patients with terminal cancer has declined because surgeons are selecting to operate on healthier patients. Fri, 01 May 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9965 Dorsey Griffith 2015-05-01T00:00:00Z NCI funding boosts breast CT scanning research and development https://www.ucdmc.ucdavis.edu/publish/news/cancer/9960/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9960 SACRAMENTO, Calif. (April 29, 2015) - John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer. Wed, 29 Apr 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9960 Dorsey Griffith 2015-04-29T00:00:00Z Comprehensive genomic tumor profiling comes to UC Davis https://www.ucdmc.ucdavis.edu/publish/news/cancer/9915/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9915 SACRAMENTO, Calif. (April 20, 2015) - The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual’s cancer. Mon, 20 Apr 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9915 Dorsey Griffith 2015-04-20T00:00:00Z UC Davis researchers win grant to answer key questions in surveillance of small lung nodules https://www.ucdmc.ucdavis.edu/publish/news/cancer/9913/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9913 SACRAMENTO, Calif. (April 15, 2015) - Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer. Wed, 15 Apr 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9913 Dorsey Griffith 2015-04-15T00:00:00Z Conquer Cancer Foundation selects UC Davis med student for award https://www.ucdmc.ucdavis.edu/publish/news/cancer/9896/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9896 SACRAMENTO, Calif. (April 7, 2015) - The Conquer Cancer Foundation has selected UC Davis medical student Angel Morán for the 2015 American Society of Clinical Oncology (ASCO) Medical Student Rotation for Underrepresented Populations. Tue, 07 Apr 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9896 Susan Mar 2015-04-07T00:00:00Z Small RNA plays big role suppressing cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/9862/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9862 SACRAMENTO, Calif. (April 2, 2015) - The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets? Thu, 02 Apr 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9862 Dorsey Griffith 2015-04-02T00:00:00Z Protein may improve liver regeneration https://www.ucdmc.ucdavis.edu/publish/news/cancer/9856/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9856 SACRAMENTO, Calif. (March 31, 2015) - Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα is far more active and efficient than the human form, allowing mice to quickly regenerate damaged livers. However, the research shows that protein fibroblast growth factor 21 (FGF21) can boost the regenerative effects of human PPARα. Tue, 31 Mar 2015 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9856 Dorsey Griffith 2015-03-31T00:00:00Z UC Davis scientists describe novel drug mechanism that fights brain cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/9777/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9777 SACRAMENTO, Calif. (March 3, 2015) - Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers. Tue, 03 Mar 2015 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9777 Dorsey Griffith 2015-03-03T00:00:00Z UC Davis designated a Lung Cancer Screening Center https://www.ucdmc.ucdavis.edu/publish/news/cancer/9715/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9715 SACRAMENTO, Calif. (February 11, 2015) - UC Davis Health System has been endorsed by the American College of Radiology as a designated lung cancer screening center, the only of its kind currently in the greater Sacramento area. Wed, 11 Feb 2015 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9715 Dorsey Griffith 2015-02-11T00:00:00Z California breast density law slow to have an impact https://www.ucdmc.ucdavis.edu/publish/news/cancer/9667/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9667 SACRAMENTO, Calif. (January 28, 2015) - Ten months after California legislators enacted a controversial law mandating that radiologists notify women if they have dense breast tissue, UC Davis researchers have found that half of primary care physicians are still unfamiliar with the law and many don’t feel comfortable answering breast density-related questions from patients. Wed, 28 Jan 2015 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9667 Susan Mar 2015-01-28T00:00:00Z Moon Chen's research featured in ASCO's 2015 cancer progress report https://www.ucdmc.ucdavis.edu/publish/news/cancer/9643/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9643 SACRAMENTO, Calif. (January 21, 2015) - UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday. Wed, 21 Jan 2015 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9643 Susan Mar 2015-01-21T00:00:00Z Too much, too little, just right https://www.ucdmc.ucdavis.edu/publish/news/cancer/9553/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9553 SACRAMENTO, Calif. (December 15, 2014) - Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels. Too much Rbm38 reduces p53 levels, increasing the risk of cancer. Too little Rbm38 allows p53 overexpression, causing premature aging. The study was published in the journal PNAS on Dec. 15.  Mon, 15 Dec 2014 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9553 Susan Mar 2014-12-15T00:00:00Z 'Tis the season to indulge in walnuts https://www.ucdmc.ucdavis.edu/publish/news/cancer/9471/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9471 SACRAMENTO, Calif. (November 13, 2014) - Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice. In addition, both walnuts and walnut oil reduced cholesterol and increased insulin sensitivity. Thu, 13 Nov 2014 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9471 Susan Mar 2014-11-13T00:00:00Z UC Davis "out-of-the-box thinker" wins cancer research award https://www.ucdmc.ucdavis.edu/publish/news/cancer/9464/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9464 SACRAMENTO, Calif. (November 12, 2014) - UC Davis medical oncologist Jonathan Riess is the recipient of a 2014 Young Innovators Team Award for Lung Cancer Research, and will share a $500,000 for translational lung cancer research with two other physician-scientists. Wed, 12 Nov 2014 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9464 Susan Mar 2014-11-12T00:00:00Z Lung cancer screening for Medicare patients coming soon to UC Davis https://www.ucdmc.ucdavis.edu/publish/news/cancer/9459/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9459 SACRAMENTO, Calif. (November 10, 2014) - UC Davis Medical Center is preparing to screen seniors on Medicare who meet the criteria for lung cancer screening using low-dose computed tomography (CT). Mon, 10 Nov 2014 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9459 Susan Mar 2014-11-10T00:00:00Z Immunotherapy for cancer toxic with obesity https://www.ucdmc.ucdavis.edu/publish/news/cancer/9429/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9429 SACRAMENTO, Calif. (November 3, 2014) - Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. [en español] Mon, 03 Nov 2014 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/9429 Susan Mar 2014-11-03T00:00:00Z UC Davis researchers examine risks, benefits of chemotherapy for early-stage breast cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/9413/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9413 SACRAMENTO, Calif. (October 31, 2014) - Treatment for early stage breast cancer is highly effective, and for many women considering treatment choices, chemotherapy may add little to an already high long-term survival rate. Joy Melnikow, professor in the Department of Family and Community Medicine and Director of the Center for Healthcare Policy and Research at UC Davis, is working to define the potential long-term harms of chemotherapy for these patients, so they can be weighed against the potential benefits. Fri, 31 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9413 Dorsey Griffith 2014-10-31T00:00:00Z Study on Western diet and role in GI cancer funded https://www.ucdmc.ucdavis.edu/publish/news/cancer/9408/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9408 SACRAMENTO, Calif. (October 28, 2014) - The National Cancer Institute (NCI) has awarded a $2.7 million grant to UC Davis researchers to investigate how the so-called Western diet, which is high in fat and sugar, increases the risk of developing liver and gastrointestinal (GI) cancers. In addition, the researchers will study whether bifidobacteria, a common family of bacteria in the human gut, can be enriched to prevent cancer. Tue, 28 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9408 Dorsey Griffith 2014-10-28T00:00:00Z Anti-cancer drug found effective against common stem cell transplant complication https://www.ucdmc.ucdavis.edu/publish/news/cancer/9394/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9394 SACRAMENTO, Calif. (October 24, 2014) - Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants. Fri, 24 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9394 Susan Mar 2014-10-24T00:00:00Z Distinguished cancer prevention researcher to lead public health sciences at UC Davis https://www.ucdmc.ucdavis.edu/publish/news/cancer/9361/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9361 SACRAMENTO, Calif. (October 21, 2014) - Brad Pollock, a leading researcher on the incidence and control of childhood and adolescent cancer, has become chair of the Department of Public Health Sciences at the UC Davis School of Medicine. Tue, 21 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9361 Karen Finney 2014-10-21T00:00:00Z NCI awards UC Davis $1.5 million to innovate robotic surgery for head and neck cancers https://www.ucdmc.ucdavis.edu/publish/news/cancer/9378/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9378 SACRAMENTO, Calif. (October 21, 2014) - The National Cancer Institute (NCI) has awarded UC Davis principal investigators Laura Marcu and Gregory Farwell $1.5 million to adapt UC Davis-developed biophotonic technology to a robotic surgical device in hopes of dramatically improving the precision of head and neck cancer surgery. Tue, 21 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9378 Susan Mar 2014-10-21T00:00:00Z Cancer Center wins $1.7 million NCI grant to study novel cancer treatment https://www.ucdmc.ucdavis.edu/publish/news/cancer/9337/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9337 SACRAMENTO, Calif. (October 10, 2014) - A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective. Fri, 10 Oct 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9337 Susan Mar 2014-10-10T00:00:00Z Cancer center's Brain Innovation Group funded for brain tumor tool https://www.ucdmc.ucdavis.edu/publish/news/cancer/9287/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9287 SACRAMENTO, Calif. (September 24, 2014) - The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology. Wed, 24 Sep 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9287 Susan Mar 2014-09-24T00:00:00Z UC Davis-developed target leukemia treatment shows promise https://www.ucdmc.ucdavis.edu/publish/news/cancer/9243/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9243 SACRAMENTO, Calif. (September 11, 2014) - Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective. Thu, 11 Sep 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9243 Susan Mar 2014-09-11T00:00:00Z Introducing the multi-tasking nanoparticle https://www.ucdmc.ucdavis.edu/publish/news/cancer/9051/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9051 SACRAMENTO, Calif. (August 26, 2014) - mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications. Tue, 26 Aug 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9051 Dorsey Griffith 2014-08-26T00:00:00Z California isn't measuring up in the fight against cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/9193/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9193 SACRAMENTO, Calif. (August 21, 2014) - In a media briefing at the UC Davis Comprehensive Cancer Center, the American Cancer Society Cancer Action Network released How Do You Measure Up?, an annual report that scores each state on how they are doing in the fight against cancer. Thu, 21 Aug 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9193 Susan Mar 2014-08-21T00:00:00Z Novel drug action against solid tumors explained https://www.ucdmc.ucdavis.edu/publish/news/cancer/9171/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9171 SACRAMENTO, Calif. (August 11, 2014) - Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. Mon, 11 Aug 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9171 Susan Mar 2014-08-11T00:00:00Z Pan awarded grant to test 'smart' chemotherapy drug for bladder cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/9168/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9168 SACRAMENTO, Calif. (August 7, 2014) - UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients. Thu, 07 Aug 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9168 Susan Mar 2014-08-07T00:00:00Z UC Davis researcher receives NSFC grant to find new gastric cancer genes https://www.ucdmc.ucdavis.edu/publish/news/cancer/9120/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9120 SACRAMENTO, Calif. (July 18, 2014) - No Stomach for Cancer Foundation (NSFC) has awarded cancer geneticist Luis Carvajal-Carmona a $50,000 grant to study the genetic characteristics of gastric cancer. Fri, 18 Jul 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9120 Susan Mar 2014-07-18T00:00:00Z Neural stem cell discovery may aid in treatment research for deafness https://www.ucdmc.ucdavis.edu/publish/news/cancer/9106/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9106 SACRAMENTO, Calif. (July 15, 2014) - Researchers at UC Davis School of Medicine have for the first time shown that a polysialylated glycoprotein that regulates neurodevelopment exists on the surface of cells in the adult inner ear. Tue, 15 Jul 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9106 Susan Mar 2014-07-15T00:00:00Z New combination drug controls tumor growth and metastasis in mice https://www.ucdmc.ucdavis.edu/publish/news/cancer/9105/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9105 SACRAMENTO, Calif. (July 14, 2014) - Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor’s ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences. Mon, 14 Jul 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/9105 Dorsey Griffith 2014-07-14T00:00:00Z Pancreatic surgery complications impact hospital costs more than length of stay https://www.ucdmc.ucdavis.edu/publish/news/cancer/8695/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8695 SACRAMENTO, Calif. (July 10, 2014) - When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers. Thu, 10 Jul 2014 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/8695 Dorsey Griffith 2014-07-10T00:00:00Z